SXD-13294-63510
4 vaccinations
5 coded responses
41 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 943 / CA
- Registered
- 2021-02-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-12
Registered in v-safe
-
2021-02-12
Dose 1 — Pfizer-BioNTech
- 2021-02-12
- 2021-02-13
- 2021-02-14
-
2021-02-15
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: Bruising near injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: Bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: Bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: Bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Survey response — day 7, dose 1MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: Bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-26
- 2021-03-05
- 2021-03-12
-
2021-03-14
Dose 2 — Pfizer-BioNTech
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-28
- 2021-04-04
- 2021-04-11
- 2021-04-19
- 2021-04-25
- 2021-06-13
- 2021-09-12
-
2021-11-22
Dose 3 — Moderna
- 2022-03-16
-
2022-06-01
Dose 4 — Pfizer-BioNTech
- 2022-06-01
- 2022-06-02
- 2022-06-04
- 2022-06-05
- 2022-06-06
- 2022-06-07
- 2022-06-08
- 2022-06-15
- 2022-06-22
- 2022-06-29
- 2022-07-06
- 2022-07-13
- 2022-08-31
- 2022-11-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-12 | Pfizer-BioNTech | |
| 2 | 2021-03-14 | Pfizer-BioNTech | |
| 3 | 2021-11-22 | Moderna | No |
| 4 | 2022-06-01 | Pfizer-BioNTech | No |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Bruising near injection site
Systemic reaction (other): Bruising at injection site
Systemic reaction (other): Bruising at injection site
Systemic reaction (other): Bruising at injection site
Release 4 — day 7, dose 1
Systemic reaction (other): Bruising at injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release